Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Muller, Y.D.; Aubert, J.D.; Vionnet, J.; Rotman, S.; Sadallah, S.; Aubert, V.; Pascual, M.

doi:10.1097/TP.0000000000002165

Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Details

Download: 29521880_pp_cover.pdf (493.82 [Ko])
State: Public
Version: Author's accepted manuscript
License: Not specified

Serval ID

serval:BIB_A55614976F55

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Journal

Transplantation

Author(s)

Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M.

ISSN

1534-6080 (Electronic)

ISSN-L

0041-1337

Publication state

Published

Issued date

06/2018

Peer-reviewed

Oui

Volume

102

Number

6

Pages

e301-e303

Language

english

Notes

Publication types: Case Reports ; Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish

Keywords

Antibodies, Monoclonal, Humanized/therapeutic use, Drug Therapy, Combination, Female, Graft Rejection/diagnosis, Graft Rejection/drug therapy, Graft Rejection/immunology, Graft Survival/drug effects, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunosuppressive Agents/therapeutic use, Isoantibodies/immunology, Lung Transplantation/adverse effects, Middle Aged, Rituximab/therapeutic use, Time Factors, Treatment Outcome

URN

urn:nbn:ch:serval-BIB_A55614976F552

OAI-PMH

oai:serval.unil.ch:BIB_A55614976F55

DOI

10.1097/TP.0000000000002165

Pubmed

29521880

Web of science

000433905600010

Create date

13/03/2018 9:34